Chronic obstructive pulmonary disease (COPD), which includes emphysema and chronic bronchitis, is a leading cause of death in the United States. The COPD National Action Plan was created to address the disease by uniting key stakeholders in the fight against it. Watch Dr. Jim Kiley and representatives from Breathe Better Network partners Atrium Health, Respiratory Health Association, and the American Lung Association discuss the impact and importance of the COPD National Action Plan on their work. This video is by Learn More, Breathe Better — a program sponsored by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH). Our goal is to bring greater visibility to lung health by translating research for public and professional education programs. Dr. Kiley is Director of NHLBI’s Division of Lung Diseases. Learn more: http://www.nhlbi.nih.gov/BreatheBetter Follow us on Twitter: http://www.twitter.com/BreatheBetter Like us on Facebook: http://www.facebook.com/BreatheBetter
National Heart, Lung, and Blood Institute
The National Heart, Lung, and Blood Institute (NHLBI) provides global leadership for a research, training, and education program to promote the prevention and treatment of heart, lung, and blood disorders and enhance the health of all individuals so that they can live longer and more fulfilling lives.
Core Mission Areas
The Science
Discover the goals, challenges, and initiatives that have shaped and will continue to shape prevention, diagnosis, and treatment for the NHLBI’s scientific focus areas.
Clinical Trials
NHLBI-funded clinical trials look at new ways to prevent, detect, or treat disease. The NHLBI is also focused on management and oversight of these trials.
Grants and Training
The NHLBI is committed to helping researchers establish independent careers. Locate the latest research and career development funding opportunities
Get In Touch
National Heart, Lung, and Blood Institute
Building 31
31 Center Drive
Bethesda, MD 20892
1-877-NHLBI4U (1-877-645-2448)
- Log in to post comments
- 42 views
- 1 view